Sectors
KRYS
Krystal Biotech, Inc.
333.15
1 x 331.91
1 x 335.00
bid
ask
+
1.56
0.47%
09:40 AM
timesize
| Ytd | 35.13% | |
| 1y | 142.22% |
331.35
day range
333.55
136.73
52 week range
382.54
| Open | 333.30 | Prev Close | 331.59 | Low | 331.35 | High | 333.55 | Mkt Cap | 9.83B |
| Vol | 3.79K | Avg Vol | 423.11K | EPS | 7.98 | P/E | 41.79 | Forward P/E | 35.03 |
| Beta | 0.53 | Short Ratio | 8.83 | Inst. Own | 101.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 339.73 | 200-d Avg | 275.95 | 1yr Est | 382.86 |
| Income Statement | |||
| Total Revenue | 119.22M | ||
| Revenues (USD) | 119.22M | ||
| Cost of Revenue | 6.44M | ||
| Gross Profit | 112.79M | ||
| Operating Expenses | 54.37M | ||
| Research and Development Expense | 14.52M | ||
| Selling, General and Administrative Expense | 39.85M | ||
| Operating Income | 58.42M | ||
| Income Tax Expense | 11.31M | ||
| Net Income | 54.77M | ||
| Net Income Common Stock | 54.77M | ||
| Net Income Common Stock (USD) | 54.77M | ||
| Consolidated Income | 54.77M | ||
| Earnings per Basic Share | 1.85 | ||
| Earnings per Basic Share (USD) | 1.85 | ||
| Earnings per Diluted Share | 1.79 | ||
| Earning Before Interest & Taxes (EBIT) | 66.08M | ||
| Earning Before Interest & Taxes (USD) | 66.08M | ||
| Weighted Average Shares | 29.53M | ||
| Weighted Average Shares Diluted | 30.66M | ||
| Balance Sheet | |||
| Cash and Equivalents | 427.74M | ||
| Cash and Equivalents (USD) | 427.74M | ||
| Investments | 675.18M | ||
| Investments Current | 417.89M | ||
| Investments Non-Current | 257.29M | ||
| Trade and Non-Trade Receivables | 138.66M | ||
| Current Assets | 1.06B | ||
| Property, Plant & Equipment Net | 160.60M | ||
| Total Assets | 1.50B | ||
| Debt Current | 1.81M | ||
| Total Debt | 8.85M | ||
| Current Liabilities | 127.40M | ||
| Debt Non-Current | 7.05M | ||
| Total Liabilities | 141.52M | ||
| Accumulated Retained Earnings (Deficit) | 134.86M | ||
| Accumulated Other Comprehensive Income | -4.33M | ||
| Shareholders Equity | 1.36B | ||
| Shareholders Equity (USD) | 1.36B | ||
| Assets Non-Current | 441.00M | ||
| Total Debt (USD) | 8.85M | ||
| Inventory | 45.56M | ||
| Liabilities Non-Current | 14.13M | ||
| Trade and Non-Trade Payables | 6.54M | ||
| Tax Assets | 38.13M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.57M | ||
| Net Cash Flow from Financing | 15.05M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -73.57M | ||
| Capital Expenditure | -3.56M | ||
| Issuance (Purchase) of Equity Shares | 15.16M | ||
| Net Cash Flow from Investing | -161.58M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -158.02M | ||
| Net Cash Flow from Operations | 74.79M | ||
| Effect of Exchange Rate Changes on Cash | -1.83M | ||
| Share Based Compensation | 14.16M | ||